Biographical Sketch
BIOGRAPHICAL SKETCH
Provide the following information for the key personnel in the order listed for Form Page 2.
Follow the sample format for each person. Do Not Exceed One (1) Page
NAME
Sihe Wang
POSITION / TITLE
Head, Section of Clinical Biochemistry
Associate Professor, Clinical Pathology (pending)
EDUCATION / TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training)
INSTITUTION AND LOCATION
DEGREE (if applicable)
YEAR(S)
FIELD OF STUDY
University of Science and Technology of China. Hefei, China
University of North Carolina at Chapel Hill. Chapel Hill, NC.
Duke University Medical Center, Durham, NC
BS
PhD
Postdoctoral Fellow
1985-1990
1995-1998
2000-2001
Specialty Interests
chromatography and mass spectrometry for specialty testing, general clinical chemistry, new biomarkers for cardiovascular or kidney diseases
Awards & Honors
2006 Lemuel J. Bowie Young Investigator Award, Chicago Section of the American Association of Clinical Chemistry, June 2006.
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 8/1/2008,
Dr. Wang has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.